Literature DB >> 10389969

Retinoids: present role and future potential.

T R Evans1, S B Kaye.   

Abstract

Vitamin A and its biologically active derivatives, retinal and retinoic acid (RA), together with a large repertoire of synthetic analogues are collectively referred to as retinoids. Naturally occurring retinoids regulate the growth and differentiation of a wide variety of cell types and play a crucial role in the physiology of vision and as morphogenic agents during embryonic development. Retinoids and their analogues have been evaluated as chemoprevention agents, and also in the management of acute promyelocytic leukaemia. Retinoids exert most of their effects by binding to specific receptors and modulating gene expression. The development of new active retinoids and the identification of two distinct families of retinoid receptors has led to an increased understanding of the cellular effects of activation of these receptors. In this article we review the use of retinoids in chemoprevention strategies, discuss the cellular consequences of activated retinoid receptors, and speculate on how our increasing understanding of retinoid-induced signalling pathways may contribute to future therapeutic strategies in the management of malignant disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389969      PMCID: PMC2362988          DOI: 10.1038/sj.bjc.6690312

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  125 in total

1.  Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.

Authors:  C Marth; G Daxenbichler; O Dapunt
Journal:  J Natl Cancer Inst       Date:  1986-12       Impact factor: 13.506

Review 2.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  Identification of a receptor for the morphogen retinoic acid.

Authors:  V Giguere; E S Ong; P Segui; R M Evans
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

Review 4.  Zinc fingers: gilt by association.

Authors:  R M Evans; S M Hollenberg
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

5.  Two distinct actions of retinoid-receptor ligands.

Authors:  J Y Chen; J Clifford; C Zusi; J Starrett; D Tortolani; J Ostrowski; P R Reczek; P Chambon; H Gronemeyer
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

6.  The AF-2 region of the retinoic acid receptor alpha mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells.

Authors:  M A Pratt; D Deonarine; C Teixeira; D Novosad; B F Tate; J F Grippo
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

7.  13-cis-retinoic acid in the treatment of oral leukoplakia.

Authors:  W K Hong; J Endicott; L M Itri; W Doos; J G Batsakis; R Bell; S Fofonoff; R Byers; E N Atkinson; C Vaughan
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

8.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

9.  Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation.

Authors:  J A Fontana
Journal:  Exp Cell Biol       Date:  1987

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  39 in total

1.  Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis.

Authors:  D W Voehringer; D L Hirschberg; J Xiao; Q Lu; M Roederer; C B Lock; L A Herzenberg; L Steinman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Th1 cytokine profile in CD4(+) T cells.

Authors:  B Y Kang; S W Chung; S H Kim; S N Kang; Y K Choe; T S Kim
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.

Authors:  Yan Dai; Anqun Chen; Ruijie Liu; Leyi Gu; Shuchita Sharma; Weijing Cai; Fadi Salem; David J Salant; Jeffrey W Pippin; Stuart J Shankland; Marcus J Moeller; Norbert B Ghyselinck; Xiaoqiang Ding; Peter Y Chuang; Kyung Lee; John Cijiang He
Journal:  Kidney Int       Date:  2017-07-27       Impact factor: 10.612

5.  Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.

Authors:  Anqun Chen; Ye Feng; Han Lai; Wenjun Ju; Zhengzhe Li; Yu Li; Andrew Wang; Quan Hong; Fang Zhong; Chengguo Wei; Jia Fu; Tianjun Guan; Bichen Liu; Matthias Kretzler; Kyung Lee; John Cijiang He
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Mol Cell Biochem       Date:  2009-05-15       Impact factor: 3.396

7.  Induction of retinol dehydrogenase 9 expression in podocytes attenuates kidney injury.

Authors:  Xuezhu Li; Yan Dai; Peter Y Chuang; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

8.  Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes.

Authors:  Ting-Chi Lu; Zhaohui Wang; Xiaobei Feng; Peter Chuang; Wei Fang; Yibang Chen; Susana Neves; Avi Maayan; Huabao Xiong; Yusen Liu; Ravi Iyengar; Paul E Klotman; John Cijiang He
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

9.  Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia.

Authors:  Yasuhiro Maeda; Terufumi Yamaguchi; Yasuki Hijikata; Miyako Tanaka; Chikara Hirase; Shunsuke Takai; Yasuyoshi Morita; Tetsuaki Sano; Jun-Ichi Miyatake; Yoichi Tatsumi; Akihisa Kanamaru
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-15       Impact factor: 4.553

10.  ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of beta-catenin via up-regulation of Axin.

Authors:  Jianrong Lu; Feng Zhang; Daqing Zhao; Liu Hong; Jie Min; Liying Zhang; Fanfan Li; Yan Yan; Hang Li; Yu Ma; Qing Li
Journal:  J Neurooncol       Date:  2008-01-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.